Palliative strategies for the management of primary and metastatic spinal tumors

Paul E. Kaloostian, Alp Yurter, Arnold B. Etame, Frank D. Vrionis, Daniel Sciubba, Ziya L. Gokaslan

Research output: Contribution to journalArticle

Abstract

Background: Technological advances during the last few decades have improved the success rate of surgery for the treatment of malignant spinal tumors. Nonetheless, many patients present with widespread tumor burden and minimal life expectancy, which excludes them from being surgical candidates. For these patients, palliative management is recommended. Methods: The authors reviewed prospective and retrospective clinical studies as well as case series regarding palliative treatments for primary and metastatic spinal tumors. Results: Analgesics, ranging from nonopioids to strong opioids, may be used depending on the degree of pain. Steroids may also improve pain relief, although they are associated with a number of adverse events. Vertebroplasty and kyphoplasty are conservative treatments with high rates of pain relief and vertebral body stabilization. Radiotherapy is the gold standard for palliative management, with approximately 60% of patients experiencing a decrease in tumor-related spinal pain and up to 35% experiencing complete relief. Stereotactic radiosurgery delivers high doses of radiation to patients to provide pain relief while also sparing delicate anatomical structures. Conclusion: Palliative management of spinal tumors is diverse. Analgesics may be used in conjunction with radiotherapy and/or kyphoplasty or vertebroplasty to offer pain relief.

Original languageEnglish (US)
Pages (from-to)140-143
Number of pages4
JournalCancer Control
Volume21
Issue number2
StatePublished - 2014

Fingerprint

Pain
Kyphoplasty
Vertebroplasty
Neoplasms
Radiotherapy
Non-Narcotic Analgesics
Radiosurgery
Life Expectancy
Tumor Burden
Palliative Care
Opioid Analgesics
Analgesics
Retrospective Studies
Steroids
Radiation
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Medicine(all)

Cite this

Kaloostian, P. E., Yurter, A., Etame, A. B., Vrionis, F. D., Sciubba, D., & Gokaslan, Z. L. (2014). Palliative strategies for the management of primary and metastatic spinal tumors. Cancer Control, 21(2), 140-143.

Palliative strategies for the management of primary and metastatic spinal tumors. / Kaloostian, Paul E.; Yurter, Alp; Etame, Arnold B.; Vrionis, Frank D.; Sciubba, Daniel; Gokaslan, Ziya L.

In: Cancer Control, Vol. 21, No. 2, 2014, p. 140-143.

Research output: Contribution to journalArticle

Kaloostian, PE, Yurter, A, Etame, AB, Vrionis, FD, Sciubba, D & Gokaslan, ZL 2014, 'Palliative strategies for the management of primary and metastatic spinal tumors', Cancer Control, vol. 21, no. 2, pp. 140-143.
Kaloostian PE, Yurter A, Etame AB, Vrionis FD, Sciubba D, Gokaslan ZL. Palliative strategies for the management of primary and metastatic spinal tumors. Cancer Control. 2014;21(2):140-143.
Kaloostian, Paul E. ; Yurter, Alp ; Etame, Arnold B. ; Vrionis, Frank D. ; Sciubba, Daniel ; Gokaslan, Ziya L. / Palliative strategies for the management of primary and metastatic spinal tumors. In: Cancer Control. 2014 ; Vol. 21, No. 2. pp. 140-143.
@article{537ec5bedf8748aabe002f51d756c3f2,
title = "Palliative strategies for the management of primary and metastatic spinal tumors",
abstract = "Background: Technological advances during the last few decades have improved the success rate of surgery for the treatment of malignant spinal tumors. Nonetheless, many patients present with widespread tumor burden and minimal life expectancy, which excludes them from being surgical candidates. For these patients, palliative management is recommended. Methods: The authors reviewed prospective and retrospective clinical studies as well as case series regarding palliative treatments for primary and metastatic spinal tumors. Results: Analgesics, ranging from nonopioids to strong opioids, may be used depending on the degree of pain. Steroids may also improve pain relief, although they are associated with a number of adverse events. Vertebroplasty and kyphoplasty are conservative treatments with high rates of pain relief and vertebral body stabilization. Radiotherapy is the gold standard for palliative management, with approximately 60{\%} of patients experiencing a decrease in tumor-related spinal pain and up to 35{\%} experiencing complete relief. Stereotactic radiosurgery delivers high doses of radiation to patients to provide pain relief while also sparing delicate anatomical structures. Conclusion: Palliative management of spinal tumors is diverse. Analgesics may be used in conjunction with radiotherapy and/or kyphoplasty or vertebroplasty to offer pain relief.",
author = "Kaloostian, {Paul E.} and Alp Yurter and Etame, {Arnold B.} and Vrionis, {Frank D.} and Daniel Sciubba and Gokaslan, {Ziya L.}",
year = "2014",
language = "English (US)",
volume = "21",
pages = "140--143",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "2",

}

TY - JOUR

T1 - Palliative strategies for the management of primary and metastatic spinal tumors

AU - Kaloostian, Paul E.

AU - Yurter, Alp

AU - Etame, Arnold B.

AU - Vrionis, Frank D.

AU - Sciubba, Daniel

AU - Gokaslan, Ziya L.

PY - 2014

Y1 - 2014

N2 - Background: Technological advances during the last few decades have improved the success rate of surgery for the treatment of malignant spinal tumors. Nonetheless, many patients present with widespread tumor burden and minimal life expectancy, which excludes them from being surgical candidates. For these patients, palliative management is recommended. Methods: The authors reviewed prospective and retrospective clinical studies as well as case series regarding palliative treatments for primary and metastatic spinal tumors. Results: Analgesics, ranging from nonopioids to strong opioids, may be used depending on the degree of pain. Steroids may also improve pain relief, although they are associated with a number of adverse events. Vertebroplasty and kyphoplasty are conservative treatments with high rates of pain relief and vertebral body stabilization. Radiotherapy is the gold standard for palliative management, with approximately 60% of patients experiencing a decrease in tumor-related spinal pain and up to 35% experiencing complete relief. Stereotactic radiosurgery delivers high doses of radiation to patients to provide pain relief while also sparing delicate anatomical structures. Conclusion: Palliative management of spinal tumors is diverse. Analgesics may be used in conjunction with radiotherapy and/or kyphoplasty or vertebroplasty to offer pain relief.

AB - Background: Technological advances during the last few decades have improved the success rate of surgery for the treatment of malignant spinal tumors. Nonetheless, many patients present with widespread tumor burden and minimal life expectancy, which excludes them from being surgical candidates. For these patients, palliative management is recommended. Methods: The authors reviewed prospective and retrospective clinical studies as well as case series regarding palliative treatments for primary and metastatic spinal tumors. Results: Analgesics, ranging from nonopioids to strong opioids, may be used depending on the degree of pain. Steroids may also improve pain relief, although they are associated with a number of adverse events. Vertebroplasty and kyphoplasty are conservative treatments with high rates of pain relief and vertebral body stabilization. Radiotherapy is the gold standard for palliative management, with approximately 60% of patients experiencing a decrease in tumor-related spinal pain and up to 35% experiencing complete relief. Stereotactic radiosurgery delivers high doses of radiation to patients to provide pain relief while also sparing delicate anatomical structures. Conclusion: Palliative management of spinal tumors is diverse. Analgesics may be used in conjunction with radiotherapy and/or kyphoplasty or vertebroplasty to offer pain relief.

UR - http://www.scopus.com/inward/record.url?scp=84897013833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897013833&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 140

EP - 143

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 2

ER -